We serve 6-methyl-5-nitro-1H-pyridin-2-one CAS:28489-45-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Contact us for information like 6-methyl-5-nitro-1H-pyridin-2-one chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Hydroxy-5-nitro-6-methylpyridin physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Hydroxy-5-nitro-6-methylpyridine Use and application,2-Hydroxy-5-nitro-6-methylpyridine technical grade,usp/ep/jp grade.
Related News: All of China’s provinces and territories have now been touched by the outbreak.DL-Butyrine manufacturer Further research on Oligomannate’s pharmacological mechanism and long-term safety and effectiveness is required, according to the NMPA statement.(3R,4S,5R,6R)-3,4,5-tris(trimethylsilyloxy)-6-(trimethylsilyloxymethyl)oxan-2-one supplier Rigosertib, in its intravenous formulation, is currently in Phase 3 clinical development for the treatment of higher-risk MDS.4-Bromo-2-Chlorobenzoic Acid vendor Rigosertib, in its intravenous formulation, is currently in Phase 3 clinical development for the treatment of higher-risk MDS.Rigosertib, in its intravenous formulation, is currently in Phase 3 clinical development for the treatment of higher-risk MDS.
